Codexis Inc (CDXS)

4.40
NASDAQ : Health Care
Prev Close 4.50
Day Low/High 4.30 / 4.55
52 Wk Low/High 3.14 / 5.29
Avg Volume 165.00K
Exchange NASDAQ
Shares Outstanding 41.38M
Market Cap 186.22M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Codexis Signs Second Multi-Year Agreement In Food Industry With Tate & Lyle

Codexis Signs Second Multi-Year Agreement In Food Industry With Tate & Lyle

Codexis to Research and Develop Novel Enzymes Supporting Tate & Lyle's Food Ingredient Growth Strategies

Codexis Completes Obligations Under Research And Development Agreement With Leading Biopharmaceutical Company

Codexis Completes Obligations Under Research And Development Agreement With Leading Biopharmaceutical Company

Enzyme developed with CodeEvolver® technology for preclinical therapeutics program exceeds agreement requirements

Codexis Files Lawsuit Against EnzymeWorks And CEO Junhua

Codexis Files Lawsuit Against EnzymeWorks And CEO Junhua "Alex" Tao For Patent Infringement And Misappropriation Of Trade Secrets

Codexis, Inc. (Nasdaq: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the filing of a lawsuit against EnzymeWorks and its founder, Junhua "Alex" Tao, for willful...